We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Robinhood
HOOD
$86.8B
| $20.6M | 0.13% |
205,779
+87,005
| +73% | +$7.28M |
2026 Q1
1 quarter
|
|
202
Bentley Systems
BSY
$11.9B
| $20.6M | 0.13% |
687,595
+675,142
| +5,422% | +$22M |
2025 Q4
2 quarters
|
|
203
Teva Pharmaceutical Industries Limited
TEVA
$46.9B
| $20.5M | 0.13% |
604,053
+69,643
| +13% | +$2.32M |
2026 Q1
1 quarter
|
|
204
Humana
HUM
$50.6B
| $20.4M | 0.13% |
+51,390
| New | +$14.6M |
2026 Q2
0 quarters
|
|
205
Sanmina
SANM
$8.28B
| $20.3M | 0.13% |
80,274
+35,284
| +78% | +$7.73M |
2025 Q4
2 quarters
|
|
206
Block Inc
XYZ
$47.5B
| $20.1M | 0.13% |
264,648
+54,863
| +26% | +$3.86M |
2025 Q4
2 quarters
|
|
207
MarketAxess Holdings
MKTX
$5.8B
| $19.6M | 0.13% |
+172,799
| New | +$24.6M |
2026 Q2
0 quarters
|
|
208
Rubrik
RBRK
$25B
| $19.6M | 0.13% |
243,730
| – | – |
2024 Q4
6 quarters
|
|
209
Acadia Healthcare
ACHC
$2.97B
| $19M | 0.12% |
643,486
+7,370
| +1% | +$189K |
2026 Q1
1 quarter
|
|
210
Adaptive Biotechnologies
ADPT
$3.9B
| $18.9M | 0.12% |
+881,688
| New | +$13.5M |
2026 Q2
0 quarters
|
|
211
Core & Main
CNM
$7.81B
| $18.9M | 0.12% |
+391,766
| New | +$19.4M |
2026 Q2
0 quarters
|
|
212
EPAM Systems
EPAM
$7.15B
| $18.8M | 0.12% |
+237,130
| New | +$25.1M |
2026 Q2
0 quarters
|
|
213
VSE Corp
VSEC
$4.16B
| $18.7M | 0.12% |
+81,931
| New | +$15.7M |
2026 Q2
0 quarters
|
|
214
Hamilton Insurance Group
HG
$3.66B
| $18.6M | 0.12% |
548,659
+55,355
| +11% | +$1.74M |
2025 Q4
2 quarters
|
|
215
Digital Realty Trust
DLR
$63.4B
| $18.5M | 0.12% |
+102,897
| New | +$19.7M |
2026 Q2
0 quarters
|
|
216
Biogen
BIIB
$37.5B
| $18.1M | 0.12% |
+83,853
| New | +$16M |
2026 Q2
0 quarters
|
|
217
PG&E
PCG
$39B
| $18.1M | 0.12% |
1,075,793
-401,915
| -27% | -$6.76M |
2024 Q4
6 quarters
|
|
218
Microchip Technology
MCHP
$40.5B
| $18.1M | 0.12% |
198,198
-224,661
| -53% | -$20M |
2025 Q2
4 quarters
|
|
219
Ralph Lauren
RL
$22.8B
| $18.1M | 0.12% |
44,971
-111,100
| -71% | -$41.4M |
2026 Q1
1 quarter
|
|
220
Lennar Class A
LEN
$20.1B
| $17.8M | 0.11% |
+196,944
| New | +$17.6M |
2026 Q2
0 quarters
|
|
221
Teradyne
TER
$48.3B
| $17.7M | 0.11% |
+36,487
| New | +$13.8M |
2026 Q2
0 quarters
|
|
222
Privia Health
PRVA
$2.92B
| $17.6M | 0.11% |
685,489
-153,985
| -18% | -$3.57M |
2025 Q2
4 quarters
|
|
223
AGCO
AGCO
$7.44B
| $17.6M | 0.11% |
+147,266
| New | +$17.1M |
2026 Q2
0 quarters
|
|
224
Veracyte
VCYT
$3.7B
| $17.6M | 0.11% |
+299,911
| New | +$12.6M |
2026 Q2
0 quarters
|
|
225
Fortive
FTV
$18.1B
| $17.1M | 0.11% |
279,467
+261,873
| +1,488% | +$15.7M |
2025 Q2
4 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.